Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations.

CONCLUSIONS: The results underscore the potential of NIPT-based tests, analyzing CNAs in plasma cfDNA in a genome-wide and unbiased fashion for breast cancer detection, cancer subtyping and treatment monitoring in a pregnant and nonpregnant target population.
PMID: 33141904 [PubMed - as supplied by publisher]

Source: Clinical Genitourinary Cancer - November 1, 2020 Category: Cancer & Oncology Authors: Lenaerts L, Che H, Brison N, Neofytou M, Jatsenko T, Lefrère H, Maggen C, Villela D, Verheecke M, Dehaspe L, Croitor A, Hatse S, Wildiers H, Neven P, Vandecaveye V, Floris G, Vermeesch JR, Amant F Tags: Clin Chem Source Type: research